Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CellCept in p-ANCA Vasculitis

This study has been completed.
Roche Pharma AG
Information provided by:
Mayo Clinic Identifier:
First received: November 29, 2006
Last updated: March 21, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):